中国继续医学教育
中國繼續醫學教育
중국계속의학교육
CHINA CONTINUING MEDICAL EDUCATION
2015年
12期
113-114
,共2页
肩锁关节脱位%患者%手术治疗
肩鎖關節脫位%患者%手術治療
견쇄관절탈위%환자%수술치료
Acromioclavicular dislocation%Patients%Surgical treatment
目的:对肩锁关节脱位患者的手术治疗方法以及效果进行分析,并对手术治疗体会进行总结。方法选取于2013年11月~2014年8月期间在我院接受治疗的35例肩锁关节脱位患者,并对所有患者进行手术治疗,对手术方法和效果进行总结。结果按照Karlsson评价标准来评定术后疗效,优27例,占比77.1%,良5例,占比14.3%,差3例,占比8.6%,则本次研究的优良率为91.4%。结论对肩锁关节脱位患者采用手术治疗具有十分显著的临床效果,并且具有固定可靠、减少疼痛、防止肩部畸形以及获得较好的肩关节功能等诸多优点。
目的:對肩鎖關節脫位患者的手術治療方法以及效果進行分析,併對手術治療體會進行總結。方法選取于2013年11月~2014年8月期間在我院接受治療的35例肩鎖關節脫位患者,併對所有患者進行手術治療,對手術方法和效果進行總結。結果按照Karlsson評價標準來評定術後療效,優27例,佔比77.1%,良5例,佔比14.3%,差3例,佔比8.6%,則本次研究的優良率為91.4%。結論對肩鎖關節脫位患者採用手術治療具有十分顯著的臨床效果,併且具有固定可靠、減少疼痛、防止肩部畸形以及穫得較好的肩關節功能等諸多優點。
목적:대견쇄관절탈위환자적수술치료방법이급효과진행분석,병대수술치료체회진행총결。방법선취우2013년11월~2014년8월기간재아원접수치료적35례견쇄관절탈위환자,병대소유환자진행수술치료,대수술방법화효과진행총결。결과안조Karlsson평개표준래평정술후료효,우27례,점비77.1%,량5례,점비14.3%,차3례,점비8.6%,칙본차연구적우량솔위91.4%。결론대견쇄관절탈위환자채용수술치료구유십분현저적림상효과,병차구유고정가고、감소동통、방지견부기형이급획득교호적견관절공능등제다우점。
Objective To analyze surgical treatment method and its effect of patients with acromioclavicular dislocation and then summarize its surgical treatment experience.Methods Choose 35 patients with acromioclavicular dislocation who are received and treated in hospital from November 2013 to August 2014 and have them cured with surgical treatment and then make a summary of treatment experience.ResultsMake an evaluation on surgery treatment effect according to Karlsson standard, the result shows that 27 cases of performance are excellent, accounting 77.1%; 5 cases of performance are good, accounting 14.3%; and 3 cases of performance are bad, accounting 8.6%, the treatment excellence rate is up to 91.4%. Conclusion Surgical treatment is of efifcacy in treatment of patients with acromioclavicular dislocation; and such a treatment method has advantages of reliable fixation and pain alleviation, prevention form shoulder deformation and improvement of shoulder function; thus, surgical treatment is quite worthwhile to be promoted and applied clinically in treatment of acromioclavicular dislocation.